External beam radiation therapy for oral squamous cell carcinoma: A narrative review
Downloads
Background: Oral cancer is a malignancy that occurs in the oral cavity. Many factors cause oral cancer, namely alcohol consumption, tobacco smoking, smokeless tobacco, chronic irritation, and others. external beam radiation therapy (EBRT) is a technology commonly used in the standard treatment of head and neck cancer. Purpose: The aim of this review was to determine the effectiveness of EBRT for oral squamous cell carcinoma. Review: Lip carcinoma has a higher chance of healing compared to other cancers that usually appear in the neck and head. Lip carcinoma can be cured through radiation therapy, namely external beam radiation therapy (EBRT). EBRT can be combined withbrachytherapy, which can improve cancer healing. Conclusion: EBRT can be used for oral squamous cell carcinoma cancer treatment. However, there are some disadvantages of EBRT that need to be reviewed based on the conditions in the patient’s case.
Michael G. Burket’s Oral Medicine. Twelfth edition. New Delhi: Jaypee Medical; 2015. 263–309 p.
Abati S, Bramati C, Bondi S, Lissoni A, Trimarchi M. Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis. Int J Environ Res Public Health. 2020 Dec 8;17(24):9160.
Nagao T, Warnakulasuriya S. Screening for oral cancer: Future prospects, research and policy development for Asia. Oral Oncol. 2020 Jun;105:104632.
Regezi JA, Sciubba JJ, Jordan RCK. Oral pathology: clinical pathologic correlations 6th ed. St. Louis, Missouri: Elsevier/ Saunders; 2012.
Irani S. New insights into oral cancer—Risk factors and prevention: A review of literature. Int J Prev Med. 2020;11(1):202.
Biasoli ÉR, Valente VB, Mantovan B, Collado FU, Neto SC, Sundefeld MLMM, et al. Lip Cancer: A Clinicopathological Study and Treatment Outcomes in a 25-Year Experience. J Oral Maxillofac Surg. 2016 Jul;74(7):1360–7.
Babu G, Ravikumar R, Rafi M, Nair L, Nazeer F, Thomas S, et al. Treatment outcomes of squamous cell carcinoma of the lip: A retrospective study. Oncol Lett. 2022 Nov 14;25(1):8.
Nandini DB, Rao RS, Hosmani J, Khan S, Patil S, Awan KH. Novel therapies in the management of oral cancer: An update. Dis Mon. 2020 Dec;66(12):101036.
Shirato H, Le Q-T, Kobashi K, Prayongrat A, Takao S, Shimizu S, et al. Selection of external beam radiotherapy approaches for precise and accurate cancer treatment. J Radiat Res. 2018 Mar 1;59(suppl_1):i2–10.
Pialat P-M, Mounie M, Podeur F, Gassa F, Suchaud J-P, Fleury B, et al. Salvage brachytherapy with or without external beam radiotherapy for oral or oropharyngeal squamous cell carcinomas in previously irradiated areas: carcinologic and toxicity outcomes of 25 patients. J Contemp Brachytherapy. 2021;13(4):402–9.
Agaku IT, Akinyele AO. Comparison of external beam radiation therapy and radioactive implants in the management of nonmetastatic oral squamous cell cancer: an analysis of the surveillance epidemiology and end results database. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jan;115(1):38–45.
Bhalavat R, Pareek V, Chandra M, Nellore L, George K, Borade D, et al. High-dose-rate interstitial brachytherapy in recurrent head and neck cancer: an effective salvage option. J Contemp Brachytherapy. 2018;10(5):425–30.
Kazemian A, Babaei M, Lashkari M, Ghalehtaki R, Garajei A, Motiee-Langroudi M, et al. Adjuvant high-dose-rate brachytherapy in the management of oral cavity cancers: 5 years of experience in Iran. J Contemp Brachytherapy. 2017;9(4):323–9.
Vedasoundaram P, Raghava KS A, Periasamy K, Selvarajan G, K S, Kandasamy S, et al. The Effect of High Dose Rate Interstitial Implant on Early and Locally Advanced Oral Cavity Cancers: Update and Long-Term Follow-Up Study. Cureus. 2020 May 1;
Blažek T, Zděblová Čermáková Z, Knybel L, Hurník P, Štembírek J, Resová K, et al. Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost. Radiat Oncol. 2021 Dec 29;16(1):122.
Cabrera-Rodríguez JJ. The role of radiotherapy in the treatment of oral cavity cancer. Plast Aesthetic Res. 2016 May 25;3(5):158–66.
Pires FR, Ramos AB, Oliveira JBC de, Tavares AS, Luz PSR da, Santos TCRB dos. Oral squamous cell carcinoma: clinicopathological features from 346 cases from a single Oral Pathology service during an 8-year period. J Appl Oral Sci. 2013 Sep;21(5):460–7.
Mendenhall WM, Holtzman AL, Dagan R, Bryant CM, Hitchcock KE, Amdur RJ, et al. Current Role of Radiotherapy in the Management of Oral Cavity Squamous Cell Carcinoma. Craniomaxillofac Trauma Reconstr. 2021 Mar;14(1):79–83.
Huang S-H, O’Sullivan B. Oral cancer: Current role of radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal. 2013 Mar 1;18(2):e233-40
Copyright (c) 2025 Jihan Fahira, Akmalisnani Putri Rifasky, Mileniatri Evriany Lestari Pakphan, Lusia Dinda Puspa L, Yasmin Kamila Putri, Zakiyyah Darojah, Dhea Rima Rohita Z, Haedar Ilhamuddin K, Jasmine Salwa SS, Gabriella Benedictine O, Malika Fadiyah, Adila Dzakiyya Rahmi, Arini Hurun’in, Farah Richana Fajrin, Aisyah Qonita Nurfitri, Covina Reyhana Azriella, Annisa Tiara Diva, Moza Zikra Loveisca, Ni Nengah Diandhary B, Sisca Meida Wati
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Lisence, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Copyright notice:
IJDM by UNAIR is licensed under a Creative Commons Atribusi 4.0 Internasional.
- The journal allows the author to hold the copyright of the article without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution (CC BY)
